| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.28 |
2e-07 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |